Festival of Genomics & Biodata 2025, Boston

UNLOCK THE FUTURE OF LIFE SCIENCES Integrate and utilize advanced technologies into drug discovery & development, disease research and healthcare The Festival of Genomics and Biodata is returning to the Boston Convention & Exhibition Center on Tuesday June 24th – Wednesday 25th June 2025. Join us for inspirational speakers, the latest research and clinical breakthroughs, […]

biomodal’s Exhibitor Spotlight Theater and Poster Sessions

Reveal the power of the 6-base genome. Introducing duet multiomics solution evoC. Distinguish 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) together with all four canonical bases to measure multiple modes of biology from a single low-input DNA sample in a single experiment. Identify novel multimodal biomarkers to gain transformative insights into current and future states of disease.

EACR Cancer Neuroscience Conference

Reveal the power of the 6-base genome. Introducing duet multiomics solution evoC. Distinguish 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) together with all four canonical bases to measure multiple modes of biology from a single low-input DNA sample in a single experiment. Identify novel multimodal biomarkers to gain transformative insights into current and future states of disease.

Keystone Symposia – Epigenetics in Development and Disease

Joint with: Interplay of Chromatin Architecture and Transcription Regulation Epigenetic modifications to our genomes impact chromatin organization and gene activity during organismal development, homeostasis and aging. Histone and DNA modifying enzymes, as well as chromatin remodelers, are frequently disrupted in developmental disorders and disease states, inspiring the development of numerous potential therapeutics to target these […]

ISMRC 2025 (International Symposium on Minimal Cancer)

Reveal the power of the 6-base genome. Introducing duet multiomics solution evoC. Distinguish 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) together with all four canonical bases to measure multiple modes of biology from a single low-input DNA sample in a single experiment. Identify novel multimodal biomarkers to gain transformative insights into current and future states of disease.

SSMG 2025 (Swiss Society of Medical Genetics)

The SGMG is a medical society. It represents the specialization of the umbrella and professional organizations (FMH and FAMH). It is responsible for the further education and training of specialists in medical genetics and specialists in laboratory medicine and medical genetics. It supports its members in their highly qualified clinical and laboratory services for patients […]

EACR 2025: Congress: Innovative Cancer Science

The 2025 Annual Congress of the European Association for Cancer Research (EACR 2025) is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations. The […]

Epigenetics-2025, from mechanisms to disease

This international conference will bring together leading experts to foster dynamic discussions on the latest breakthroughs in epigenetics. It will cover mechanisms of epigenetic regulation across various fields and explore how these mechanisms are deregulated in disease states. The Epigenetics-2025 conference will also provide a platform for early-career and senior scientists to collaborate, exchange ideas, […]

Deutsche Gesellschaft für Humangenetik

The German Society for Human Genetics (GfH) was founded in 1987 and is a nationwide scientific association of medical specialists and natural scientists working in the field of human genetics. One of the central tasks of the GfH is to promote human genetics in all areas of research, teaching and practice. This is done in […]

AGBT 2025

The General Meeting is AGBT’s flagship event for bringing together global leaders, researchers, and innovators. Advances in Genome Biology and Technology (AGBT) delivers a premier experience where heads of labs, institutions, businesses, financial analysts and other high-level stakeholders come together to advance the field and drive game-changing innovation. Significant scientific advances are announced and showcased, […]